Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 36, Pages e2105815118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-08-20
DOI
10.1073/pnas.2105815118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
- (2021) Shuofeng Yuan et al. NATURE
- Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
- (2021) Mark Dittmar et al. Cell Reports
- Reconstructed Single-Cell Fate Trajectories Define Lineage Plasticity Windows during Differentiation of Human PSC-Derived Distal Lung Progenitors
- (2020) Killian Hurley et al. Cell Stem Cell
- COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission
- (2020) Jinyang Gu et al. GASTROENTEROLOGY
- Evidence for gastrointestinal infection of SARS-CoV-2
- (2020) Fei Xiao et al. GASTROENTEROLOGY
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Digestive Symptoms in COVID-19 Patients With Mild Disease Severity
- (2020) Chaoqun Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antiviral Effects of Bovine Lactoferrin on Human Norovirus
- (2020) Hirotsugu Oda et al. Biochemistry and Cell Biology
- COVID-19 presenting as stroke
- (2020) Akshay Avula et al. BRAIN BEHAVIOR AND IMMUNITY
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Pathogenesis of COVID-19 from a cell biology perspective
- (2020) Robert J. Mason EUROPEAN RESPIRATORY JOURNAL
- Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
- (2020) Lu Lin et al. GUT
- Cardiac and arrhythmic complications in patients with COVID‐19
- (2020) Adriano Nunes Kochi et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
- (2020) Francisco Alejandro Lagunas‐Rangel et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
- (2020) Shuofeng Yuan et al. PHARMACOLOGICAL RESEARCH
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
- (2020) Douglas B. Kell et al. Frontiers in Immunology
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- (2020) Mehdi Bouhaddou et al. CELL
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
- (2020) Ayal B. Gussow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Quantifying Drug Combination Synergy along Potency and Efficacy Axes
- (2019) Christian T. Meyer et al. Cell Systems
- The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9
- (2019) Mélissa K. Mariani et al. Cells
- Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells
- (2019) Anjali Jacob et al. Nature Protocols
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
- (2018) Susen Burock et al. BMC CANCER
- Z-FA-FMK demonstrates differential inhibition of aquatic orthoreovirus (PRV), aquareovirus (CSRV), and rhabdovirus (IHNV) replication
- (2018) Olivia Roscow et al. VIRUS RESEARCH
- CellProfiler 3.0: Next-generation image processing for biology
- (2018) Claire McQuin et al. PLOS BIOLOGY
- Secretoglobin Superfamily Protein SCGB3A2 Alleviates House Dust Mite-Induced Allergic Airway Inflammation in Mice
- (2016) Mitsuhiro Yoneda et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression
- (2016) Wei Chen et al. MEDICAL SCIENCE MONITOR
- Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity
- (2015) Jörg Täubel et al. PLoS One
- Immunomodulatory effects of lactoferrin
- (2014) Tania Siqueiros-Cendón et al. ACTA PHARMACOLOGICA SINICA
- Lactoferrin prevents LPS-induced decrease of the iron exporter ferroportin in human monocytes/macrophages
- (2014) Antimo Cutone et al. BIOMETALS
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
- (2011) Jianshe Lang et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started